Shares of medical equipment maker Mettler-Toledo International (MTD) surged 5.14% in the pre-market Friday, after the company provided an upbeat annual profit forecast for 2025.
Mettler-Toledo expects its adjusted profit per share for the full year 2025 to be between $42.35 and $43.00, exceeding analysts' average estimate of $42.13. The company cited strong demand for its laboratory instruments used in drug development as a key driver behind the bullish profit outlook.
The positive annual forecast comes on the heels of Mettler-Toledo's better-than-expected fourth quarter performance. For the period ended December 31st, the company reported an adjusted profit of $12.41 per share, beating Wall Street's consensus estimate of $11.71 per share. Quarterly sales also topped expectations, rising 12% year-over-year to $1.05 billion.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.